絞り込み

16610

広告

運動は中高年から始めても遅くない (日経BP)

運動は総死亡、心血管疾患、癌のリスク低下に関係することが示されている。しかし、多くの研究では、ベースラインの運動量とアウトカムの関係を調べており、その後の生活習...

  1. 医学部受験「バブル」はひとまず終息しまし...
  2. 無給医、労基署による全大学病院の緊急点検...
  3. 転移性前立腺癌の治療はより早期に新規AR...
  4. しばしば誤嚥性肺炎の原因となる意外なあの...

ニュース一覧

The Somatostatin Receptor-4 Agonist J-2156 Alleviates Mechanical Hypersensitivity in a Rat Model of Breast Cancer Induced Bone Pain.

著者 Shenoy PA , Kuo A , Khan N , Gorham L , Nicholson JR , Corradini L , Vetter I , Smith MT
Front Pharmacol.2018 ; 9():495.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (71view , 0users)

Full Text Sources

In the majority of patients with breast cancer in the advanced stages, skeletal metastases are common, which may cause excruciating pain. Currently available drug treatments for relief of breast cancer-induced bone pain (BCIBP) include non-steroidal anti-inflammatory drugs and strong opioid analgesics along with inhibitors of osteoclast activity such as bisphosphonates and monoclonal antibodies such as denosumab. However, these medications often lack efficacy and/or they may produce serious dose-limiting side effects. In the present study, we show that J-2156, a somatostatin receptor type 4 (SST4 receptor) selective agonist, reverses pain-like behaviors in a rat model of BCIBP induced by unilateral intra-tibial injection of Walker 256 breast cancer cells. Following intraperitoneal administration, the ED of J-2156 for the relief of mechanical allodynia and mechanical hyperalgesia in the ipsilateral hindpaws was 3.7 and 8.0 mg/kg, respectively. Importantly, the vast majority of somatosensory neurons in the dorsal root ganglia including small diameter C-fibers and medium-large diameter fibers, that play a crucial role in cancer pain hypersensitivities, expressed the SST4 receptor. J-2156 mediated pain relief in BCIBP-rats was confirmed by observations of a reduction in the levels of phosphorylated extracellular signal-regulated kinase (pERK), a protein essential for central sensitization and persistent pain, in the spinal dorsal horn. Our results demonstrate the potential of the SST4 receptor as a pharmacological target for relief of BCIBP and we anticipate the present work to be a starting point for further mechanism-based studies.
PMID: 29867498 [PubMed]
印刷用ページを開く Endnote用テキストダウンロード